Imperial College London

DrDavidErritzoe

Faculty of MedicineDepartment of Medicine

Honorary Clinical Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 7047d.erritzoe

 
 
//

Location

 

Neuropsychopharmacology UnitBurlington DanesHammersmith Campus

//

Summary

 

Summary

Post-doctoral Researcher and Academic Clinical Fellow, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London.

 

  • Graduation from Medical School, Copenhagen University, Copenhagen, Denmark in 2001.
  • In the following years medical training in internal medicine, surgery, and psychiatry at hospitals in Copenhagen.
  • Under Professor Marc Laruelle at Columbia University in New York City 2003-04 trained in molecular brain imaging in schizophrenia and addiction.
  • PhD thesis “PET studies of serotonergic neurotransmission”, using these imaging techniques completed at the Neurobiology Research Unit and Center for Integrated Molecular Brain Imaging (CIMBI), University Hospital Rigshospitalet, Copenhagen.
  • Since 2009 under the mentorship of Professors Anne Lingford-Hughes and David Nutt at Imperial College London continuing research in brain imaging in addiction using both PET and fMRI.
  • Involved in several lines of psychopharmacological and brain imaging research at Imperial; investigating dopaminergic neurotransmission with measurements of the dopamine D3 receptor in alcohol addiction, studies of opioid neurotransmission in pathological gambling, and functional imaging studies looking at the role of dopamine D3 and mu-opiate receptors in cocaine, alcohol, and heroin addiction. In addition, together with Prof Nutt and Dr Carhart-Harris conducting brain imaging of the acute effects of MDMA and psychedelic compounds.
  • In 2012 nominated a Academic Clinical Fellowship in Psychiatry under Imperial College, and from February 2013 been working in clinical psychiatry in West London, and part time in research at Imperial.

 

Publications

Journals

Laursen HR, Henningsson S, Macoveanu J, et al., 2016, Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use, Journal of Psychopharmacology, Vol:30, ISSN:0269-8811, Pages:1296-1304

Mick I, Myers J, Ramos AC, et al., 2016, Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers, Neuropsychopharmacology, Vol:41, ISSN:0893-133X, Pages:1742-1750

Carhart-Harris RL, Murphy K, Leech R, et al., 2015, The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity, Biological Psychiatry, Vol:78, ISSN:0006-3223, Pages:554-562

Nutt DJ, Lingford-Hughes A, Erritzoe D, et al., 2015, The dopamine theory of addiction: 40 years of highs and lows, Nature Reviews Neuroscience, Vol:16, ISSN:1471-003X, Pages:305-312

Paterson LM, Flechais RSA, Murphy A, et al., 2015, The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description, Journal of Psychopharmacology, Vol:29, ISSN:0269-8811, Pages:943-960

More Publications